Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

bluebird bio: How to play LEAPS options for growth and income: https://www.marketbeat.com/logos/articles/med_20240226111048_option-blue-stock.jpg
bluebird bio: How to play LEAPS options for growth and income

Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT from CRISPR Therapeutics AG

Thinking long-term? Don't lose interest in Pinterest: https://www.marketbeat.com/logos/articles/med_20240226120753_thinking-long-term-dont-lose-interest-in-pinterest.jpg
Thinking long-term? Don't lose interest in Pinterest

Pinterest Inc. (NYSE: PINS) stock suffered a 12% sell-off on its Q4 2023 earnings report. The main reason for the selling was a miss on the top line, as revenues failed to beat consensus analyst

Salesforce stock got a boost. Is it growing off the Nvidia boom?: https://www.marketbeat.com/logos/articles/med_20240226114104_salesforce-stock-got-a-boost.jpg
Salesforce stock got a boost. Is it growing off the Nvidia boom?

Most hype surrounds technology stocks, particularly after the king of the sector, Nvidia Corp. (NASDAQ: NVDA), kept breaking past all-time high prices on ever-increasing financial expansion. There

Eilt: Durchbruch in der Krebsforschung - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73736/aktiencheck27022401.001.png
Eilt: Durchbruch in der Krebsforschung - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Durchbruch in der Krebsforschung - 100 mal wirksamer gegen Krebs. 525% Biotech Aktientip nach 15.973% mit BioNTech

 

27.02.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Is The Trade Desk signaling the rebound of digital advertising?: https://www.marketbeat.com/logos/articles/med_20240225154933_chartz-ttd.jpg
Is The Trade Desk signaling the rebound of digital advertising?

The Trade Desk Inc. (NASDAQ: TTD) is a leading independent programmatic advertising technology (AdTech) platform provider. Its demand-side platform (DSP) allows companies to automate their digital

Domino’s stock or Papa John’s? Follow price action to find out: https://www.marketbeat.com/logos/articles/med_20240226091810_dominos-stock-or-papa-johns-follow-price-action-to.jpg
Domino’s stock or Papa John’s? Follow price action to find out

Most of the market is now focused on the hype in the high-flying technology stocks today, where names like NVIDIA (NASDAQ: NVDA) keep delivering insane financial results to help the stock break

Is CRISPR Therapeutics the NVIDIA of gene editing?: https://www.marketbeat.com/logos/articles/med_20240225160343_chart-crsp.jpg
Is CRISPR Therapeutics the NVIDIA of gene editing?

CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approval for a gene-editing therapy for

Analysts boosted Snowflake stock, big firms are buying now: https://www.marketbeat.com/logos/articles/med_20240225194338_analysts-boosted-snowflake-stock-big-firms-are-buy.jpg
Analysts boosted Snowflake stock, big firms are buying now

All the market hype is now focusing on the world of technology stocks, especially after the massive run-up in names like Nvidia Corporation (NASDAQ: NVDA) and other companies involved with the

Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73714/aktiencheck26022401.001.png
Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)

 

26.02.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Link

Bloomin’ Brands could blossom in 2024: https://www.marketbeat.com/logos/articles/med_20240223074736_chart-blmn-2232024ver001.png
Bloomin’ Brands could blossom in 2024

Bloomin’ Brands (NASDAQ: BLMN) served mixed results for Q4 and provided tepid guidance, but repositioning efforts have the restaurant stock set up to blossom in 2024. A massive closure effort

Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73699/AC-230224.001.png
Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. 415% Biotech Hot Stock nach 15.973% mit BioNTech

 

23.02.24 08:03

AC Research

 

London (www.aktiencheck.de , Anzeige)

 

Keurig-Dr Pepper stock: Time to take another sip?: https://www.marketbeat.com/logos/articles/med_20240222121921_chart-kdp-2222024ver001.png
Keurig-Dr Pepper stock: Time to take another sip?

Keurig Dr Pepper's (NASDAQ: KDP) share price fell following the Q4 results and guidance for 2024, setting up the next buying opportunity. The market is down but aligning with a bottoming pattern

Rivian shares gets discounted; shares can move lower: https://www.marketbeat.com/logos/articles/med_20240222100045_chart-rivn-2222024ver001.png
Rivian shares gets discounted; shares can move lower

Rivian’s (NASDAQ: RIVN) Q4 release further proves that the EV market bubble has burst. Internal metrics and guidance suggest demand has peaked and current capacity is too much. The takeaway is

Top-Rated AMD nears major breakout level: https://www.marketbeat.com/logos/articles/med_20240222062548_amd.jpg
Top-Rated AMD nears major breakout level

While shares of Advanced Micro Devices (NASDAQ: AMD) might not grab the headlines as much as its competitor, Nvidia (NASDAQ: NVDA), shareholders of the global semiconductor company are undoubtedly

AI powerhouse NVIDIA will hit $1000 soon: https://www.marketbeat.com/logos/articles/med_20240222065539_chart-nvda-2222024ver001.png
AI powerhouse NVIDIA will hit $1000 soon

Traders and investors fearing an NVIDIA (NASDAQ: NVDA)-led market correction can put those fears to rest. The company’s Q4 results reveal that the AI market is still strong, stronger than expected

How to use iron condors to collect income from stock options: https://www.marketbeat.com/logos/articles/med_20240221122132_iron-intc.jpg
How to use iron condors to collect income from stock options

Achieving risk-free passive income from the stock market is the dream of investors. Unfortunately, nothing in the stock market are risk-free. However, if you are willing to have a cap on your

Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73679/aktiencheck22022401.001.png
Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. 400% Biotech Aktientip nach 9.290% mit Novo-Nordisk

 

22.02.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

3 Reasons the Capital One-Discover merger is a big deal: https://www.marketbeat.com/logos/articles/med_20240221114956_3-reasons-the-capital-one-discover-merger-is-a-big.jpg
3 Reasons the Capital One-Discover merger is a big deal

What’s in your wallet? In the not-so-distant future, it might be a card issued by the combined entity of Capital One Financial Corp. (NYSE: COF) and Discover Financial Services (NYSE: DFS)

Spotify sounding better to analysts as company tunes into profits: https://www.marketbeat.com/logos/articles/med_20240220131029_spotify-sounding-better-to-analysts-as-company-tun.jpg
Spotify sounding better to analysts as company tunes into profits

Spotify Technology S.A. (NYSE: SPOT) is trading at its best levels since December 2021 on the strength of hardy revenue growth and a return to profitability. 

Spotify is a global music streaming

Informatica charges ahead on AI-driven data management tailwinds: https://www.marketbeat.com/logos/articles/med_20240218153655_charts-infa.jpg
Informatica charges ahead on AI-driven data management tailwinds

Informatica Inc. (NASDAQ: INFA) offers its artificial intelligence (AI) platform for enterprises to unify and manage their data to unlock transformative outcomes. The computer and technology

Eilt: Durchbruch in Krebsforschung: 100 mal wirksamer gegen Krebs. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73659/aktiencheck210224.001.png
Eilt: Durchbruch in Krebsforschung: 100 mal wirksamer gegen Krebs. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Durchbruch in Krebsforschung: 100 mal wirksamer gegen Krebs. Neuer 407% Biotech Hot Stock nach 15973% mit BioNTech

 

21.02.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Walmart’s uptrend is intact; buy it when it dips: https://www.marketbeat.com/logos/articles/med_20240220072702_chart-wmt-2202024ver001.png
Walmart’s uptrend is intact; buy it when it dips

Walmart (NYSE: WMT) is in an uptrend and will likely continue. The Q4 results and guidance for 2024 underpin an expectation for capital returns and improving shareholder value for this retail

These 5 stocks have unique competitive edge and room to run: https://www.marketbeat.com/logos/articles/med_20240219114803_these-5-stocks-have-unique-competitive-edge-and-ro.jpg
These 5 stocks have unique competitive edge and room to run

A prominent investment theme of the past year is the outperformance of profitable companies with a unique competitive advantage.

Obvious examples of stocks in that category include Nvidia Corp.

Higher VIX just made Realty Income’s 6% dividend better: https://www.marketbeat.com/logos/articles/med_20240219114215_higher-vix-just-made-realty-incomes-6-dividend-bet.jpg
Higher VIX just made Realty Income’s 6% dividend better

Patient investors look for safer stocks when the VIX begins to pop to protect their portfolio or expose themselves to high-quality assets at potential discountsRealty Income (NYSE: O) could be